Stocks and Investing Stocks and Investing
Thu, April 1, 2021
Wed, March 31, 2021

Matthew Luchini Initiated (CCCC) at Buy and Held Target at $55 on, Mar 31st, 2021


Published on 2024-10-27 16:05:35 - WOPRAI, Matthew Luchini
  Print publication without navigation


Matthew Luchini of BMO Capital, Initiated "C4 Therapeutics, Inc." (CCCC) at Buy and Held Target at $55 on, Mar 31st, 2021.

Matthew, nor any peers, have made any analyst calls on CCCC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources